Efficacy and safety of treatment regimens for patients with metastatic, locally advanced, or recurrent breast cancer carrying BRCA1/BRCA2 pathogenic variants: A network meta-analysis

OBJECTIVE: Patients with breast cancer carrying BRCA1 and BRCA2 genetic alterations show poor prognoses. However, the efficacy of pharmacotherapies for patients with advanced breast cancer carrying BRCA1/2 pathogenic variants remains unclear. This study aimed to conduct a network meta-analysis to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yingxuan, Li, Yang, Liu, Weida, Zhou, Ruozhu, Tse, Lap Ah, Wang, Yang, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971004/
https://www.ncbi.nlm.nih.gov/pubmed/36865806
http://dx.doi.org/10.3389/fonc.2023.1080297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971004/
https://www.ncbi.nlm.nih.gov/pubmed/36865806
http://dx.doi.org/10.3389/fonc.2023.1080297

Ejemplares similares